These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36848686)

  • 1. CYP102A1 peroxygenase catalyzed reaction via in situ H
    Hardiyanti Oktavia FAR; Nguyen NA; Park CM; Cha GS; Nguyen THH; Yun CH
    J Inorg Biochem; 2023 May; 242():112165. PubMed ID: 36848686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective carbon-hydrogen bond hydroxylation using an engineered cytochrome P450 peroxygenase.
    Akter J; Stockdale TP; Child SA; Lee JHZ; De Voss JJ; Bell SG
    J Inorg Biochem; 2023 Jul; 244():112209. PubMed ID: 37080140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of human chiral metabolites of simvastatin and lovastatin by bacterial CYP102A1 mutants.
    Kim KH; Kang JY; Kim DH; Park SH; Park SH; Kim D; Park KD; Lee YJ; Jung HC; Pan JG; Ahn T; Yun CH
    Drug Metab Dispos; 2011 Jan; 39(1):140-50. PubMed ID: 20962060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
    Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
    Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
    Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH
    Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of the human metabolite piceatannol from the anticancer-preventive agent resveratrol by bacterial cytochrome P450 BM3.
    Kim DH; Ahn T; Jung HC; Pan JG; Yun CH
    Drug Metab Dispos; 2009 May; 37(5):932-6. PubMed ID: 19237510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric cytochromes P450 engineered by domain swapping and random mutagenesis for producing human metabolites of drugs.
    Kang JY; Ryu SH; Park SH; Cha GS; Kim DH; Kim KH; Hong AW; Ahn T; Pan JG; Joung YH; Kang HS; Yun CH
    Biotechnol Bioeng; 2014 Jul; 111(7):1313-22. PubMed ID: 24474032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regioselective hydroxylation of omeprazole enantiomers by bacterial CYP102A1 mutants.
    Ryu SH; Park BY; Kim SY; Park SH; Jung HJ; Park M; Park KD; Ahn T; Kang HS; Yun CH
    Drug Metab Dispos; 2014 Sep; 42(9):1493-7. PubMed ID: 25008345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.
    Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN
    J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regioselective C-H hydroxylation of omeprazole sulfide by Bacillus megaterium CYP102A1 to produce a human metabolite.
    Jang HH; Ryu SH; Le TK; Doan TT; Nguyen TH; Park KD; Yim DE; Kim DH; Kang CK; Ahn T; Kang HS; Yun CH
    Biotechnol Lett; 2017 Jan; 39(1):105-112. PubMed ID: 27640009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
    Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
    J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of the cytochrome P450 peroxygenase enzymes.
    Munro AW; McLean KJ; Grant JL; Makris TM
    Biochem Soc Trans; 2018 Feb; 46(1):183-196. PubMed ID: 29432141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Strategies for Modifying Cytochrome P450 Monooxygenases into Peroxizymes.
    Fan S; Cong Z
    Acc Chem Res; 2024 Jan; ():. PubMed ID: 38293787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and activation parameters for oxidations of styrene by Compounds I from the cytochrome P450(BM-3) (CYP102A1) heme domain and from CYP119.
    Yuan X; Wang Q; Horner JH; Sheng X; Newcomb M
    Biochemistry; 2009 Sep; 48(38):9140-6. PubMed ID: 19708688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites.
    Damsten MC; van Vugt-Lussenburg BM; Zeldenthuis T; de Vlieger JS; Commandeur JN; Vermeulen NP
    Chem Biol Interact; 2008 Jan; 171(1):96-107. PubMed ID: 17996858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous detection of NADPH consumption and H
    Morlock LK; Böttcher D; Bornscheuer UT
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):985-994. PubMed ID: 29150709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of critical residues for peroxygenation and improved peroxygenase activity via
    Pardhe BD; Oh TJ
    Front Microbiol; 2023; 14():1296202. PubMed ID: 38149268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multienzymatic in situ hydrogen peroxide generation cascade for peroxygenase-catalysed oxyfunctionalisation reactions.
    Pesic M; Willot SJ; Fernández-Fueyo E; Tieves F; Alcalde M; Hollmann F
    Z Naturforsch C J Biosci; 2019 Feb; 74(3-4):101-104. PubMed ID: 30379645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationships between cytochromes P450 and H
    Albertolle ME; Peter Guengerich F
    J Inorg Biochem; 2018 Sep; 186():228-234. PubMed ID: 29990746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
    Cha GS; Ryu SH; Ahn T; Yun CH
    Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.